The formation of oxygen-containing heterocycles via intramolecular cyclizations of halo-substituted acylsilanes and unsaturated acylsilanes

DOI: 10.1016/S0040-4020(99)00936-9

Source and publish data:

Tetrahedron p. 14587 - 14598 (1999)

Update date:2022-08-03

Topics:

Authors:

Tsai, Yeun-Min

Cherng, Chaur-Donp

Nieh, Hong-Chang

Sieh, Jiuen-Ahn

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4020(99)00936-9

Halo-substituted acylsilanes undergo cyclizations easily when heated in a polar solvent such as NMP to afford 2-silyldihydrofurans and 2- silyldihydropyrans. Unsaturated acylsilanes undergo cyclizations through reactions with iodine, phenylselenenyl bromi

Full text of DOI:10.1016/S0040-4020(99)00936-9

Products guided by the article

Product name:6-methyldiphenylsilyl-2-phenylselenenylmethyl-3,4-dihydro-2H-pyran

Cas No:256506-29-3

R&D Labs maybe for 256506-29-3

Hangzhou Fandachem Co.,Ltd

Contact:+86-158-5814-5714

Address:No.9 YanAn Road,Hangzhou,Zhejiang,China
Shanghai Micro-mega Industry Co., Ltd.

Contact:0086-21-34628682;57153848

Address:Rm413,No.413,West Meilong Road, Minhang District,Shanghai P R China
WUHAN WELLSONG INT'L CO.,LTD

Contact:+86-27-85733560

Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Wuhan Soleado Technology Co.,Ltd.

Contact:86-2783341481 18971291927

Address:RM2405 Unit 1 Builing 1, Taiyin Tower, Changqing Road,Wuhan China
Changzhou Xuanming Chemical Co., Ltd.

Contact:86 0519 85525329

Address:China Town, Xinbei, Changzhou, Jiangsu Room 6019

Relevant to this article

Doi:10.1016/S0040-4039(01)87573-0
(1970)
Total synthesis of 5-N-acetylardeemin and amauromine: Practical routes to potential MDR reversal agents

Doi:10.1021/ja991558d
(1999)
The first asymmetric syntheses of L-homocysteine and L-homocystine

Doi:10.1016/S0957-4166(99)00453-X
(1999)
Doi:10.1039/j39700000583
(1970)
Doi:10.1039/j39690002425
(1969)
On peptide syntheses. 33.3. On angiotensin analogues. Synthesis of lys-6-val-5-, of tyr-3-val-5-, of tyr(Me)-4-val-5- and of tyr-8-val-5-angiotensin II-asp-l-beta amide

Doi:10.1002/jlac.19656840129
(1965)

Article Doi